Current rates of oxygen prescribing remain unsatisfactory despite doctors being made aware of the audit findings. Education on oxygen therapy improved the delivery of oxygen therapy to patients on a respiratory ward.

Ineffective inhaler technique is a common problem that can lead to poor disease management and an increase in the frequency of exacerbations. It is not always down to patients choosing to use inhalers in an inappropriate way, as evidence suggests health professionals are often found to be lacking in their ability to correctly teach inhaler technique. This article looks at the evidence regarding incorrect use of inhalers and the common themes associated with poor technique. It also provides a step-by-step guide on appropriate use of the more commonly prescribed inhalers.

Aim:To investigate the efficacy of 2 different education strategies for teaching and maintaining inhaler technique in older patients. Conclusion:Inhaler technique in older patients is often poor. They are often able to use inhalers correctly when instructed but maintenance of good technique is not prevalent across all devices.In older patients a more structured approach to teaching inhaler technique is no more effective than usual care.

Steven Hickey outlines the role of patient education and personalized management plans in preventing and reducing the frequency of exacerbations of COPD

This article highlights the cost implications when prescribing the different delivery devices available for salmeterol/fluticasone (Seretide, Allen & Hanburys) in patients with chronic obstructive pulmonary disease (COPD). The prescribing licence for combination inhalers in COPD is specific to both drug dosing and delivery device. The perception amongst some practitioners is that patients with moderate to severe airflow obstruction (FEV1 <60%) are unable to generate sufficient inspiratory flow to adequately use the Accuhaler. This audit found this not to be the case and recommends that independent prescribers can prescribe the licenced device confident that patients with COPD can generate sufficient inspiratory flow. The cost savings are significant if patients can be changed from the Evohaler to the Accuhaler.